Paricalcitol
8 NDCs across 4 manufacturers|8 Generic,0 Brand
Paricalcitol is used to treat hyperparathyroidism, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 17, 1998, and the first generic was approved Jul 27, 2011. FDA's Orange Book lists 21 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Paricalcitol across 28,000 claims for 6,476 beneficiaries.
Paricalcitol is available as 8 NDCs from 4 manufacturers (8 generic, 0 brand), with NADAC prices from $1.28 to $12.97 per EA — the most expensive product costs about 10× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
8G / 0B
Manufacturers
4
competing in market
Price Spread
$1.28 – $12.97
per EA
7d Activity
avg +0.5% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Vitamin D2 Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing PARICALCITOL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PARICALCITOL 2 MCG CAPSULE | $12.9667 per EA | — |
PARICALCITOL 1 MCG CAPSULE | $3.2164 per EA | — |
PARICALCITOL 2 MCG CAPSULE | $2.5886 per EA | -2.26% |
PARICALCITOL 2 MCG CAPSULE | $2.5886 per EA | -2.26% |
PARICALCITOL 2 MCG CAPSULE | $2.5886 per EA | -2.26% |
PARICALCITOL 1 MCG CAPSULE | $1.2772 per EA | +3.30% |
PARICALCITOL 1 MCG CAPSULE | $1.2772 per EA | +3.30% |
PARICALCITOL 1 MCG CAPSULE | $1.2772 per EA | +3.30% |
Frequently Asked Questions
What is Paricalcitol used to treat?
Paricalcitol is used to treat hyperparathyroidism, per the National Library of Medicine's MED-RT classification.
When did Paricalcitol become available as a generic?
FDA approved the first generic Paricalcitol (ANDA) on Jul 27, 2011. The Orange Book currently lists 21 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Paricalcitol?
In 2024, Medicare Part D spent $3 million on Paricalcitol across 28,000 claims for 6,476 beneficiaries.
How many Paricalcitol products are on the market?
The Paricalcitol drug market contains 8 NDCs from 4 manufacturers — 8 generic and 0 brand products.
What is the price range for Paricalcitol?
NADAC reference prices for Paricalcitol range from $1.2772 to $12.9667 per EA — the most expensive product costs about 10× the cheapest.
Which manufacturers make Paricalcitol?
4 manufacturers list Paricalcitol in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (2), Bionpharma Inc. (2), Aurobindo Pharma Limited (2), Time-Cap Labs Inc. (2).
How has the price of Paricalcitol changed recently?
Over the past 7 days, 5 Paricalcitol NDCs rose and 5 fell, with a market-wide average change of +0.5%.